Metyrapone pretreatment prevents the behavioral and neurochemical sequelae induced by stress

Brain Research

Volumn 800, Issue 2, 1998, Pages 227-235

  Calvo, Nelson ^a   Martijena, Irene D ^a   Molina, Víctor A ^a   Volosin, Marta ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Anxiety; Chloride ion flux; Corticosterone; Elevated plus maze; GABA; Metyrapone; Stress

Indexed keywords

4 AMINOBUTYRIC ACID; CHLORIDE; CORTICOSTERONE; DEXAMETHASONE; METYRAPONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; IMMOBILIZATION STRESS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CHLORIDES; CORTICOSTERONE; DEXAMETHASONE; GAMMA-AMINOBUTYRIC ACID; MALE; MAZE LEARNING; METYRAPONE; RATS; RATS, WISTAR; RECEPTORS, GABA-A; RESTRAINT, PHYSICAL; STRESS;

EID: 0032479986     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00515-0     Document Type: Article

References (57)

1. Albonetti M.E., Farabollini F. Behavioral responses to single and repeated restraint in male and female rats. Behav. Processes. 28:1992;97-110.
2. Báez M., Siriczman I., Volosin M. Corticosterone is involved in foot-shock-induced inactivity in rats. Physiol Behav. 60:1996;795-801.
3. Bennett M.C., Diamond D.M., Fleshner M., Rose G.M. Serum corticosterone levels predicts the magnitude of hippocampal primed burst potentiation and depression in urethane-anesthetized rats. Psychobiology. 19:1991;301-307.
4. Berger F.M. Effect of antianxiety drugs on fear and stress. Behav. Sci. 25:1980;315-325.
5. Biggio G., Concas A., Corda M.G., Giorgi O., Sanna E., Serra E. GABAergic and dopaminergic transmission in the rat cerebral cortex: effect of stress, anxiolytic and anxiogenic drugs. Pharmacol. Ther. 48:1990;121-142.
6. B. Bohus, Limbic-midbrain mechanisms and behavioral physiology interactions with CRF, ACTH and adrenal hormones, in: D. Hellhammer, I. Florin, H. Weiner (Eds.), Neurobiological Approaches to Human Disease, Hans Huber, Toronto, 1987, pp. 267-285.
7. Crawley J.N., Glowa J.R., Majewska M.D., Paul S.M. Anxiolytic activity of endogenous adrenal steroid. Brain Res. 270:1986;382-386.
8. Cruz A.P.M., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1994;171-176.
9. M. Davis, The role of the amygdala in conditioned fear, in: J.P. Aggleton (Ed.), The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental dysfunction, Wiley, New York, 1992, pp. 255-305.
10. de Kloet E.R. Brain corticosteroid receptor balance and homeostatic control. Front. Neuroendocrinol. 12:1991;95-164.
11. de Souza E.B., Goeders N.E., Kuhar M.J. Benzodiazepine receptors in rat brain are altered by adrenalectomy. Brain Res. 381:1986;176-181.
12. Diamond D.M., Bennett M.C., Fleshner M., Rose G.M. Inverted-U relationship between the level of peripheral corticosterone secretion and the magnitude of hippocampal primed burst potentiation. Hippocampus. 2:1992;421-430.
13. File S.E., Vellucci S.V., Wendlandt S. Corticosterone - an anxiogenic or an anxiolytic agent? J. Pharm. Pharmacol. 31:1979;300-305.
14. S.E. File, Interactions of anxiolytic and antidepressant drugs with hormones of the hypothalamic-pituitary-adrenal axis, in: W.C. Bowman (Ed.), Psychopharmacology of Anxiolytics and Antidepressants, Pergamon, Glasgow, 1991, pp. 29-47.
15. Gilad G.M., Habey J.M., Gilad V.H. Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Life Sci. 40:1987;2401-2408.
16. Graeff F.C., Guimaraes F.S., de Andrade T.G.C.S., Deakin J.F.W. Role of 5-HT in stress, anxiety and depression. Pharm. Biochem. Behav. 54:1996;129-141.
17. Handley S.L., Mc Blane J.W. An assessment of the elevated X-maze for studying anxiety-modulating drugs. J. Pharmacol. Toxicol. Methods. 29:1993;129-138.
18. Harris R.A., Allan A.M. Functional coupling of GABA receptors to chloride channels in brain membranes. Science. 228:1985;1108-1110.
19. M. Joels, E.R. de Kloet, Control of neuronal excitability by corticosteroid hormones, Trends Neurosci., 1992, pp. 25-30.
20. Joels M., Hesen W., de Kloet E.R. Long term control of neuronal excitability by corticosteroid hormones. J. Steroid Biochem. Mol. Biol. 53:1995;315-323.
21. 3H] GABA receptor binding in rat brain Brain Res. 236:1982;365-374.
22. Korte S.M., De Boer S.F., De Kloet E.R., Bohus B. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze. Psychoneuroendocrinology. 20:1995;385-394.
23. Korte S.M., Korte-Bouws G.A.H., Koob G.F., De Kloet E.R., Bohus B. Mineralocorticoid and glucocorticoid receptor antagonists in animal models of anxiety. Pharmacol. Biochem. Behav. 54:1996;261-267.
24. Le Doux J.E. Emotional memory systems the brain. Behav. Brain Res. 58:1993;68-79.
25. Levitt E.E., Persky H., Brady J.P., Fitzgerald J.A. The effect of hydrocortisone infusion on hypnotically induced anxiety. Psychosom. Med. 25:1963;158-161.
26. O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem., (1951) 266-275.
27. A receptors in brain. Brain Res. 339:1985;178-182.
28. Majewska M.D., Skolnick P., Paul S.M. Pregnenolone and corticosterone: possible modulators of the GABA/benzodiazepine receptor complex. Soc. Neurosci Abstr. 11:1985;279.
29. Majewska M.D. Antagonist-type interaction of glucocorticoids with the GABA receptor-coupled chloride channel. Brain Res. 418:1987;377-382.
30. A receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38:1992;379-395.
31. Martijena I.D., Calvo N., Volosin M., Molina V. Prior exposure to a brief restraint session facilitates the occurrence of fear in response to a conflict situation: behavioral and neurochemical correlates. Brain Res. 752:1997;136-142.
32. McEwen B.S. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 12:1991;141-147.
33. Mendelson S.D., McEwen B.S. Autoradiographic analyses of the effects of adrenalectomy and corticosterone on 5-HT 1A and 1B in the dorsal hippocampus and cortex of the rat. Neuroendocrinol. 55:1992;444-450.
34. Miller L.G., Greenblatt D.J., Barnhill J.G., Thompson M.L., Shaderh R.I. Modulation of benzodiazepine receptors in rat brain are alterated by adrenalectomy and steroid replacement. Brain Res. 446:1988;314-320.
35. Murphy B.E.P. Some studies of the protein-binding of steroids and their application to the routine micro- and ultramicro measurements of various steroids in body fluids by competitive protein-binding radio assay. J. Clin. Endocrinol. Metab. 27:1967;973-983.
36. Oitzl M.S., de Kloet E.R. Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning. Behav. Neurosci. 106:1992;62-71.
37. Otero-Losada M.E. Acute stress and GABAergic function in the rat brain. Br. J. Pharmacol. 93:1988;483-490.
38. S.M. Paul, R.D. Schwartz, M. Wess, M.D. Majewska, P. Suzdak, P. Skolnick, Stress-related post-translational modification on the benzodiazepine/GABA/barbiturate receptor complex, Am. College of Neuropsychopharmacol Abstracts, 1985, p. 22.
39. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arms in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
40. Piazza P.V., Maccari S., Deminière J.M., Le Moal M., Mormède P., Simon H. Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc. Natl. Acad. Sci. USA. 88:1991;2088-2092.
41. Piazza P.V., Le Moal M. Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res. Rev. 25:1997;359-372.
42. Reul J.M.H.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology. 117:1985;2505-2512.
43. Reul J.M.H.M., van den Bosch F.R., de Kloet E.R. Differential response of type 1 and type 2 corticosteroid receptors to changes in plasma steroid levels and circadian rhythmicity. Neuroendocrinology. 45:1989;407-412.
44. R.J. Rodgers, J.C. Cole, The elevated plus maze: pharmacology, methodology and ethology, in: S.J. Cooper, C.A. Hendrie (Eds.), Ethology and Psychopharmacology, Wiley, New York, 1994, pp. 9-44.
45. Roozendaal B., Bohus B., Mc Gaugh J.L. Dose dependent suppression of adrenocortical activity with metyrapone: effects on emotion and memory. Psychoneuroendocrinology. 21:1994;297-306.
46. Sachar E.J. Psychological factors relating to activation and inhibition of the adrenocortical response in man: a review. Prog. Brain Res. 32:1970;316-324.
47. Schwartz R.D., Wess M.J., Labarca R., Skolnick P., Paul S.M. Acute stress enhances the activity of GABA receptor-gated chloride ion channel in brain. Brain Res. 411:1987;151-155.
48. Smythe J.W., Murphy D., Timothy C., Costall B. Muscarinic antagonists are anxiogenic in rats tested in the black-white box. Pharmacol. Biochem. Behav. 54:1996;57-63.
49. Spencer R.L., Young E.A., Choo P.H., McEwen B.S. Adrenal steroid type I and type II receptor binding: estimates of in vivo receptor number, occupancy, and activation with varying level of steroid. Brain Res. 514:1990;37-48.
50. Steffens A.B. A method from frequent sampling blood and continuous infusion of fluids in the rat without disturbing the animal. Physiol. Behav. 4:1969;833-836.
51. Sutanto W., de Kloet E.R. Species-specificity of corticosteroid receptors in hamster and rat brains. Endocrinology. 121:1987;1405-1411.
52. Treit D., Pesold C., Rotzinger S. Dissociating the anti-fear effects of septal and amygdaloid lesions using two pharmacologically validated models of rat anxiety. Behav. Neurosci. 107:1993;770-785.
53. Warburton D.M. Modern biochemical concepts of anxiety. Int. J. Neuropsychiatry. 9:1974;189-205.
54. Weiss J.M., McEwen B.S., Silva M., Kalkut M. Pituitary-adrenal alterations and fear responding. Am. J. Physiol. 218:1970;864-868.
55. A benzodiazepine receptors in the mouse Brain Res. 519:1990;347-350.
56. Wilson M.A., Biscardi R. Sex differences in GABA/benzodiazepine receptor changes and corticosterone release after acute stress in rats. Exp. Brain Res. 101:1994;297-309.
57. Zacharko R.M., Koszycki D., Mendella P.D., Bradwejn J. Behavioral, neurochemical, anatomical and electrophysiological correlates of panic disorder: multiple transmitter interaction and neuropeptide colocalization. Prog. Neurobiol. 47:1995;371-423.